1. Stocks
  2. Mineralys Therapeutics Inc
  3. Swot
swot-logo

Mineralys Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mineralys Therapeutics Inc has 20 Strengths, 4 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Second Resistance ( LTP > R2)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Positive Breakout (LTP > R2)

Stock gained more than 20% in one month

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Biggest Price Gainers from Open

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks